Evidence map›Paper›PMID 35503199›Full record

ArticleStem cell reviews and reports2022

Differentiation Epitopes Define Hematopoietic Stem Cells and Change with Cell Cycle Passage.

Laura R Goldberg, Mark S Dooner, Elaine Papa, Mandy Pereira, Michael Del Tatto, Yan Cheng, Sicheng Wen, Peter J Quesenberry

Open access · hybridAbstract read
In one paragraph

Article in Stem cell reviews and reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. The Essence of Quiescence.Stem cells and development · 2024
    Review
  3. Review
  4. The universal stem cell.Leukemia · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Laura R GoldbergDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Mark S DoonerDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA. mdooner@lifespan.org.ORCID 0000-0003-0653-6562
Elaine PapaDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Mandy PereiraDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Michael Del TattoDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Yan ChengDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Sicheng WenDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Peter J QuesenberryDivision of Hematology/Oncology, Rhode Island Hospital/Brown University, 1 Hoppin St Coro West Building suite 5.01, Providence, RI, 02903, USA.
Brown University · US

Funding

Stem Cells and AgingP20GM119943 · NIGMS · RHODE ISLAND HOSPITAL · PI WEBB, ASHLEY E · 2017 to 2021
$10.6M
TYORISINE PHOSPHATASE SHP2 IN HEMATOPOIETIC STEM CELL PROPERTY MAINTENANCEP20RR025179 · NCRR · RHODE ISLAND HOSPITAL · PI ALIOTTA, JASON M · 2009 to 2011
$6.4M
Re-evalulating the hematopoetic stem cell pool to enhance the transplantable populationK08HL118117 · NHLBI · RHODE ISLAND HOSPITAL · PI GOLDBERG, LAURA RACHEL · 2015 to 2019
$791k
NCRR NIH HHS P20 RR025179NHLBI NIH HHS K08 HL118117NIGMS NIH HHS P20 GM119943
6 · The paper itself

Abstract

Hematopoietic stem cells express differentiation markers B220 and Gr1 and are proliferative. We have shown that the expression of these entities changes with cell cycle passage. Overall, we conclude that primitive hematopoietic stem cells alter their differentiation potential with cell cycle progression. Murine derived long-term hematopoietic stem cells (LT-HSC) are cycling and thus always changing phenotype. Here we show that over one half of marrow LT-HSC are in the population expressing differentiation epitopes and that B220 and Gr-1 positive populations are replete with LT-HSC after a single FACS separation but if subjected to a second separation these cells no longer contain LT-HSC. However, with second separated cells there is a population appearing that is B220 negative and replete with cycling c-Kit, Sca-1 CD150 positive LT-HSC. There is a 3-4 h interval between the first and second B220 or GR-1 FACS separation during which the stem cells continue to cycle. Thus, the LT-HSC have lost B220 or GR-1 expression as the cells progress through cell cycle, although they have maintained the c-kit, Sca-1 and CD150 stem cells markers over this time interval. These data indicate that cycling stem cells express differentiation epitopes and alter their differentiation potential with cell cycle passage.

Indexed as

Antigens, DifferentiationHematopoietic Stem CellsAnimalsCell CycleCell DifferentiationEpitopesMiceAntigens, DifferentiationEpitopesCell cycleDifferentiationHematopoietic stem cellsLineage positive cellsStem cell purification

Identifiers

PMID35503199
PMCPMC9489557
OpenAlexW4225324734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.